Lina A. Shehadeh

SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease.

Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells.

Dynamic regulation of vascular myosin light chain (MYL9) with injury and aging.

MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle.

Ribonucleic acid biomarkers for heart failure is there a correlation between heart and blood transcriptomics?

Severe hypoxia exerts parallel and cell-specific regulation of gene expression and alternative splicing in human mesenchymal stem cells.

miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice.

Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.

Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.

Differential expression of microRNAs among cell populations in the regenerating adult mouse olfactory epithelium.

Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.

New incriminating evidence against IGF2.

Osteopontin Expression in Cardiomyocytes Is Increased in Pediatric Patients With Sepsis or Pneumonia.

Deletion of Osteopontin Enhances β₂-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes.

Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.

A preclinical model for phenogroup 3 HFpEF.

Nuclear Osteopontin Is a Marker of Advanced Heart Failure and Cardiac Allograft Vasculopathy: Evidence From Transplant and Retransplant Hearts.

Osteopontin and LDLR Are Upregulated in Hearts of Sudden Cardiac Death Victims With Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus.

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol.

β-Adrenergic receptor agonism as a therapeutic strategy for kidney disease.

Carvedilol and exercise combination therapy improves systolic but not diastolic function and reduces plasma osteopontin in Alport mice.

Peptide-Modified Biopolymers for Biomedical Applications.

Development and piloting of an instructional video quality checklist (IVQC).

Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low-Density Lipoprotein Receptor Expression.

Autoimmune Reaction Associated With Long COVID Syndrome and Cardiovascular Disease: A Genetic Case Report.

Echocardiography protocol: A tool for infrequently used parameters in mice.

Ascending aortic aneurysm and histopathology in Alport syndrome: a case report.

Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.

ADAMTSL2 mutations determine the phenotypic severity in geleophysic dysplasia.